However, the significance of this melanoma model is unclear, since human melanoma tumors rarely harbor PBRM1 mutations25 and RCC demonstrated distinct immune cell-inflamed signatures that were different than melanoma and most other type of tumors26. This evidence concerns the gene PBRM1 and renal cell carcinoma.